Eppendorf has introduced the high-capacity fixed-angle Rotor FA-6x250 for up to 6 x 250 mL bottles. The Rotor FA-...
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the Nationa...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it has received CE Mark for Ortho’s...
Bionano Genomics, a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensiti...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the U.S. Food and Drug Admini...
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) has announced that...
Alcon, the global leader in eye care and a division of Novartis has acquired PowerVision, Inc., a privately-held, US-bas...
The U.S. Food and Drug Administration has approved a new indication for a heart valve repair device that is intended to ...
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinic...
Dornier MedTech (Dornier), the global leader in stone management that pioneered Extracorporeal Shockwave Lithotripter (E...
Hematogenix, a global leader in the field of integrated pathology services for drug development and immuno-oncology test...
Merck, a leading science and technology company, has announced a collaboration agreement with Iktos, for the use of its ...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical...
BPU Holdings' entity in the US, BPU International, has partnered with SEVA Technology to collaborate on research and imp...
Medicen Paris Region, Europe’s leading health competitiveness cluster has supported four of the eight winners in t...
Oxford Nanopore has made Flongle starter packs available to purchase, after initial testing in an early-access programme...
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global company which is fully integrated contract developmen...
